STVN

MKT CAP:$5B

Stevanato Group SpA

Market Cap

$5B

Healthcare·Medical Instruments & Supplies·🇺🇸 United States·NYSE

Healthcare·Medical·🇺🇸·NYSE

Stock Price

$18.00-$2.58 (-12.54%)

Jun 8, 2026

52W High $27.9552W Low $13.43

Company Details

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia...

CEO

—

IPO Date

Jul 16, 2021

Website

www.stevanatogroup.com

Key Metrics TTM (EUR)

Revenue

€1.2B

+6.7% YoY

Net Income

€141M

EPS (Diluted)

Free Cash Flow

-€7M

Revenue / Share

€4.40

Gross Margin

29.0%

Operating Margin

16.6%

Net Margin

11.7%

FCF Margin

-0.6%

P/S

P/E

Earnings Reports

Q2 2026

Aug 4, 2026

PENDING

Q1 2026

May 7, 2026

€274M+6.6%

FY 2025

Mar 4, 2026

€1.1B+3.2%

Q4 2025

Mar 4, 2026

€343M+3.8%

Q3 2025

Nov 6, 2025

€303M+9.1%

Revenue & Profitability (EUR)

Operating Cash Flow (EUR)

CapEx Spend (EUR)

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation (EUR)

OpEx Breakdown (EUR)

War Chest (EUR)

Shares Outstanding

Revenue Per Employee (EUR)

Revenue / Employee